MacuCLEAR logo — Pioneering innovative treatments for vascular eye disorders...

MacuCLEAR

Pioneering innovative treatments for vascular eye disorders with promising clinical success.

Founded 2006 Venture round Total: $1.00M Biotechnology, Health Care +1

General Information

Company Name MacuCLEAR
Founded Year 2006
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with MacuCLEAR. To contact MacuCLEAR, visit macuclear.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MacuCLEAR compare?

A PDF of MacuCLEAR and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MacuCLEAR soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MacuCLEAR

MacuCLEAR is a pioneering clinical-stage pharmaceutical company founded in 2006 that specializes in developing innovative treatments for vascular eye disorders. With the slogan "Pioneering innovative treatments for vascular eye disorders with promising clinical success," MacuCLEAR aims to revolutionize the biotechnology, health care, and pharmaceutical industries. The company holds an active IND for MC-1101 and has successfully completed a Phase Ib/POC human clinical trial, showcasing promising progress in its research and development. The last recorded investment for MacuCLEAR was a $1.00M Venture Round investment on 03 January 2012, signifying investor confidence in the company's potential.

Business keywords: ophthalmology, pharmaceuticals, clinical-stage, vascular eye disorders, innovative treatments, MC-1101, human clinical trial, IND, vascular disorders, clinical trial, drug development, medical research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.00M -
03 Jan 2012

MacuCLEAR Alternatives & Competitors

View All Alternatives
MacuCLEAR vs

DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS

Venture round
2 employees
Biopharma, Biotechnology
MacuCLEAR vs

Pioneering non-opioid pain therapeutics for post-surgical care.

Post-IPO Equity
Biotechnology, Health Care
MacuCLEAR vs
Prilenia
Prilenia United States

Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorde...

Series B
57 employees
Biotechnology, Health Care

FAQ About MacuCLEAR

Pioneering innovative treatments for vascular eye disorders with promising clinical success.
MacuCLEAR was founded in 2006.
MacuCLEAR operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on ophthalmology, pharmaceuticals, clinical-stage and vascular eye disorders.
MacuCLEAR has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Venture round.
Top alternatives and competitors to MacuCLEAR include IXALTIS SA, Recro Pharma, Prilenia, Nacuity Pharmaceuticals, Inc., IAMA Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MacuCLEAR and IXALTIS SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MacuCLEAR, https://bouncewatch.com/company/macuclear, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes